← FDA DRUG APPROVALS

FDA ANDA · ANDA087446

CHLOROPROCAINE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA087446
TYPE
ANDA
ORIGINAL APPROVAL
1982-04-16
LATEST ACTION
2021-06-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CHLOROPROCAINE HYDROCHLORIDEDiscontinued
CHLOROPROCAINE HYDROCHLORIDE 3% · INJECTABLE · INJECTION

Approval history

2021-06-22Labeling · Supplement 19 · standardAP
2010-04-16Labeling · Supplement 15AP
2005-03-29Labeling · Supplement 10AP
2002-10-25Manufacturing (CMC) · Supplement 9AP
1996-10-03Manufacturing (CMC) · Supplement 6AP
1982-09-23Manufacturing (CMC) · Supplement 1AP
1982-04-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →